Enhancement of adriamycin toxicity by iron chelates is not a free radical mechanism

Biological Trace Element Research

Volumn 56, Issue 3, 1997, Pages 295-309

  Gelvan, Dan ^a  

^a HEBREW UNIVERSITY   (Israel)

Author keywords

DNA; Electron spin resonance (ESR); Escherichia coli; Oxygen; Semiquinone

Indexed keywords

DOXORUBICIN; FREE RADICAL; IRON CHELATE;

ARTICLE; CELL KILLING; CYTOTOXICITY TEST; DNA STRAND BREAKAGE; DRUG ACTIVITY; DRUG CYTOTOXICITY; DRUG MECHANISM; ESCHERICHIA COLI; NONHUMAN;

EID: 0030968676     PISSN: 01634984     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02785301     Document Type: Article

References (51)

1. S. Sato, M. Iwaizumi, K. Handa, and Y. Tamura, Electron spin resonance study of the mode of generation of free radicals of daunomycin, adriamycin, and carboquone in NAD(P)H-microsome system, Gann 68, 603-608 (1977).
2. B. Kalyanaraman, E. Perez-Reyes, and R. P. Mason, Spin-trapping and direct electron spin resonance investigations of the redox metabolism of quinone anticancer drugs, Biochim. Biophys. Acta 630, 119-130 (1980).
3. V. Berlin and W. A. Haseltine, Reduction of adriamycin to a semiquinone-free radical by NADPH cytochrome P-450 reductase produces DNA cleavage in a reaction mediated by molecular oxygen. J. Biol. Chem. 256, 4747-4756 (1981).
4. K. Handa, and S. Sato, Generation of free radicals of quinone group-containing anticancer chemicals in NADPH-microsome system as evidenced by initiation of sulfite oxidation, Gann 66, 43 (1975).
5. J. W. Lown, S.-K. Sim, K. C. Majumdar, and R.-Y. Chang, Strand scission of DNA by bound adriamycin and daunorubicin in the presence of reducing agents, Biochem. Biophys. Res. Commun. 76, 705-710 (1977).
6. N. R. Bachur, S. L. Gordon, M. V. Gee, and H. Kon, NADPH cytochrome P-450 reductase activation of quinone anticancer agents to free radicals, Proc. Natl. Acad. Sci. USA 76, 954-957 (1979).
7. J. Schreiber, C. Mottley, B. K. Sinha, B. Kalyanaraman, and R. P. Mason, One-electron reduction of daunomycin, daunomycinone, and 7-deoxydaunomycinone by the xanthine/xanthine oxidase system: detection of semiquinone free radicals by electron spin resonance, J. Am. Chem. Soc. 109, 348-351 (1987).
8. W. S. Thayer, Adriamycin stimulated superoxide formation in submirochondrial particles, Chem. Biol. Interactions 19, 265-278 (1977).
9. N. R. Bachur, M. V. Gee, and R. D. Friedman, Nuclear catalyzed antibiotic free radical formation, Cancer Res. 42, 1078-1081 (1982).
10. 2 consumption and free radicals formation, Res. Commun. Chem. Pathol. Pharmacol. 44, 445-459 (1984).
11. - generating redox system in hepatoma 22a nuclei, Free Rad. Res. Commun. 3, 47-55 (1987).
12. C. A. Henderson, E. N. Metz, S. P. Balcerzak, and A. L. Sagone, Jr., Adriamycin and Daunomycin generate reactive oxygen compounds in erythrocytes, Blood 52, 878-885 (1978).
13. J. H. Doroshow, Effect of doxorubicin (D) on oxygen radical metabolism in Ehrlich ascites tumor (EAT) cells, Proc. Am. Assoc. Cancer Res. 22, 805 (1981).
14. B. K. Sinha, A. G. Katki, G. Batist, K. H. Cowan, and C. E. Myers, Adriamycin-stimulated hydroxyl radical formation in human breast tumor cells, Biochem. Pharmacol. 36, 793-796 (1987).
15. A. E. Alegria, A. Samuni, J. B. Mitchell, P. Riesz, and A. Russo, Free radicals induced by adriamycin-sensitive and adriamycin-resistant cells: a spin-trapping study, Biochemistry 28, 8653-8658 (1989).
16. S. Rajagopalan, P. M. Politi, B. K. Sinha, and C. E. Myers, Adriamycin-induced free radical formation in the perfused rat heart: implications for cardiotoxicity, Cancer Res. 48, 4766-4769 (1988).
17. J. Goodman and P. Hochstein, Generation of free radicals and lipid peroxidation by redox cycling of adriamycin and daunomycin, Biochem. Biophys. Res. Commun. 77, 797-803 (1977).
18. C. E. Myers, W. P. McGuire, R. H. Liss, I. Ifrim, K. Grotzinger, and R. C. Young, Adriamycin: The role of lipid peroxidation in cardiac toxicity and tumor response, Science 197, 165-167 (1977).
19. H. G. Keizer, H. M. Pinedo, G. J. Schuurhuis, and H. Joenje, Doxorubicin (adriamycin): a critical review of free radical-dependent mechanisms of cytotoxicity, Phartnacol. Ther. 47, 219-231 (1990).
20. 10-enzymes, succinoxidase and NADH-oxidase, by adriamycin and other quinones having antitumor activity, Biochem. Biophys. Res. Commun. 58, 633-638 (1974).
21. K. J. Davies and J. H. Doroshow, Redox cycling of anthracyclines by cardiac mitochondria. I. Anthracycline radical formation by NADH dehydrogenase, J. Biol. Chem. 261, 3060-3067 (1986).
22. S. A. Akman, J. H. Doroshow, T. G. Burke, and M. Dizdaroglu, DNA base modifications induced in isolated human chromatin by NADH dehydrogenase-catalyzed reduction of doxorubicin, Biochemistry 31, 3500-3506 (1992).
23. T. Komiyama, T. Oki, and T. J. Inui, A proposed reaction mechanism for the enzymatic reductive cleavage of glycosidic bond in anthracycline antibiotics, J. Antibiot. 32, 1219-1222 (1979).
24. B. K. Sinha and J. L. Gregory, Role of one-electron and two-electron reduction products of adriamycin and daunomycin in deoxyribonucleic acid binding, Biochem. Pharmacol. 30, 2626-2629 (1981).
25. J. F. Van Vleet, L. Greenwood, V. J. Ferrans, and A. H. Rebar, Effect of selenium-vitamin E on adriamycin-induced cardiomyopathy in rabbits, Am. J. Vet. Res. 39, 997-1010 (1978).
26. J. H. Doroshow, G. Y. Locker, I. Ifrim, and C. E. Myers, Prevention of doxorubicin cardiac toxicity in the mouse by N-acetylcysteine, J. Clin. Invest. 68, 1053-1064 (1981).
27. 10, Toxicol. Lett. 12, 75-82 (1982).
28. J. H. Doroshow, Prevention of doxorubicin-induced killing of MCF-7 human breast cancer cells by oxygen radical scavengers and iron chelating agents, Biochem. Biophys. Res. Commun. 135, 330-335 (1986).
29. E. Monti and B. K. Sinha, Potentiation of doxorubicin cytotoxicity by (+)-1,2-bis-(3,5-dioxopiperazinyl-1-yl)propane (ICRF-187) in human leukemic HL-60 cells, Cancer Commun. 2, 145-149 (1990).
30. G. R. Fisher and L. H. Patterson, Lack of involvement of reactive oxygen in the cytotoxicity of mitoxantrone, C1941 and ametantrone in MCF-7 cells: comparison with doxorubicin, Cancer Chemother. Pharmacol. 30, 451-458 (1992).
31. T. J. Lin, G. T. Liu, Y. Liu, and G. S. Xu, Protection by salvianolic acid A against adriamycin toxicity on rat heart mitochondria, Free Rad. Biol. Med. 12, 347-351 (1992).
32. M. N. Benchekroun, P. Catroux, D. Montaudon, and J. Robert, Development of mechanisms of protection against oxidative stress in doxorubicin-resistant rat tumoral cells in culture, Free Rad. Res. Commun. 11, 137-144 (1990).
33. D. Gelvan and A. Samuni, Cellular targets of adriamycin-induced damage in Escherichia coli, Biochem. Pharmacol. 35, 3267-3275 (1986).
34. P. L. Gutierrez, M. V. Gee, and N. R. Bachur, Kinetics of anthracycline antibiotic free radical formation and reductive glycosidase activity, Arch. Biochem. Biophys. 223, 68-75 (1983).
35. A. Samuni, A. J. Carmichael, A. Russo, J. B. Mitchell, and P. Riesz, On the spin-trapping and ESR detection of oxygen-derived radicals generated inside cells, Proc. Natl. Acad. Sci. USA 83, 7593-7597 (1986).
36. T. G. Spiro, S. E. Allerton, J. Renner, A. Terzis, R. Bils, and P. Saltman, The hydrolytic polymerization of iron(III), J. Am. Chem. Soc. 88, 2721-2726 (1966).
37. 2 and DNA damage in xthA mutants of E. coli, in Superoxide and Superoxide Dismutase in Chemistry, Biology and Medicine, G. Rotilio, ed., Eisevier, Amsterdam, pp. 343-345 (1986).
38. 2 and o-phenanthroline, in Superoxide and Superoxide Dismutase in Chemistry, Biology and Medicine, G. Rotilio, ed., Eisevier, Amsterdam, pp. 346-348 (1986).
39. J. R. White and H. N. Yeowell, Iron enhances the bactericidal action of streptonigrin, Biochem. Biophys. Res. Commun. 106, 407-411 (1982).
40. J. H. Doroshow, Anthracycline antibiotic-stimulated superoxide, hydrogen peroxide, and hydroxyl radical production by NADH dehydrogenase, Cancer Res. 43, 4543-4551 (1983).
41. M. J. Turner, D. B. Everman, S. P. Ellington, and C. E. Fields, Detection of free radicals during the cellular metabolism of adriamycin, Free Rad. Biol. Med. 9, 415-421 (1990).
42. A. Samuni and G. Czapski, Radiation-induced damage in Escherichia coli B: the effect of superoxide radicals and molecular oxygen, Radiat. Res. 76, 624-632 (1978).
43. J. Aronovitch, D. Godinger, A. Samuni, and G. Czapski, The effect of cell-bound copper on the toxicity of superoxide and vitamin C, in Oxygen Radicals in Chemistry and Biology, W. Bors, M. Saran and D. Tait, eds., Berlin, Walter de Gruyter, pp. 219-223 (1984).
44. P. Korbashi, R. Kohen, J. Katzhendler, and M. Chevion, Iron mediates paraquat toxicity in Escherichia coli, J. Biol. Chem. 261, 12472-12476 (1986).
45. R. Kohen and M. Chevion, Transition metals potentiate paraquat toxicity, Free Rad. Res. Commun. 1, 78-88 (1985).
46. S. R. Powell and A. J. Tortolani, Recent advances in the role of reactive oxygen intermediates in ischemic injury, J. Surg. Res. 53, 417-429 (1992).
47. R. Kohen, M. Szyf, and M. Chevion, Quantitation of single and double-strand DNA breaks in vitro and in vivo, Anal. Biochem. 154, 485-491 (1986).
48. F. A. Fornari, J. K. Randolph, J. C. Yalowich, M. K. Ritke, and D. A. Gewirtz, Interference by doxorubicin with DNA unwinding in MCF-7 breast tumor cells, Mol. Pharmacol. 45, 649-656 (1994).
49. K. M. Tewey, T. C. Rowe, L. Yang, B. D. Halligan, and L. F. Liu, Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II, Science 226, 466-468 (1984).
50. G. Aubel-Sadron and D. Londos-Gagliardi, Daunorubicin and doxorubicin, anthracycline antibiotics, a physicochemical and biological review, Biochimie 66, 333-352 (1984).
51. J. R. Muindi, B. K. Sinha, L. Gianni, and C. E. Myers, Hydroxyl radical production and DNA damage induced by anthracycline-iron complex, FEBS Lett. 172, 226-230 (1984).